4,4,5,5-tetramethyl-2-(3-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)-1,3,2-dioxaborolane, 98%, 250mg

4-Borono-1-naphthoic acid, 95.0%, 10g

Pentane [Standard Material for GC]>99.5%(GC)5mL

2-CHLORO-7,8-DIHYDRO-1,6-NAPHTHYRIDIN-5(6H)-ONE, 95.0%, 1g

3-Benzyl 1-tert-butyl azetidine-1,3-dicarboxylate, 97%, 5g

2-(3,4-Dichlorophenyl)-2-methylpropanoic acid, 98%, 1g

5-Methyl-2'-O,4'-C-methylenecytidine, 5g

1-Bromo-2-isopropoxy-4-(trifluoromethyl)benzene, 95+%, 1g

rac trans-3,4-Diphenyl-pyrrolidine, 98.0%, 1g

N-(4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide, 98%, 100mg

LONAFARNIB, 99%, 25mg

3,5-Dimethyl-4-propoxyphenylboronic acid, 95.0%, 25g

(S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid, 95%, 250mg